Moderna appoints Andres to new President role, Collins as CTOQO effective Jan 1, 2023

Moderna, Inc.

Juan Andres transitions to President, Strategic Partnerships and Enterprise Expansion; retains Executive Committee seat.
Jerh Collins joins as Chief Technical Operations & Quality Officer, effective Jan 1, 2023; from Novartis with 30 yrs manufacturing experience.
Executive Committee expanded to prepare for multiple new product launches; Andres led COVID vaccine production.
Collins will focus on expanding production footprint globally; starts Oct 3, 2022, assumes role Jan 1, 2023.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Juan Andres

President, Strategic Partnerships and Enterprise Expansion

MRNA · Moderna, Inc.

Effective: 2023-01-01
Successor: Jerh Collins
Filed: September 29, 2022, 7:59 PM ET

On September 29, 2022, Moderna, Inc. (the “Company”) announced that Juan Andres, the Company’s Chief Technical Operations and Quality Officer, will transition into a new role as President, Strategic Partnerships and Enterprise Expansion of the Company, effective January 1, 2023.

Appointed

Jerh Collins

Chief Technical Operations and Quality Officer

MRNA · Moderna, Inc.

Effective: 2023-01-01
Filed: September 29, 2022, 7:59 PM ET

The Company further announced that Dr. Jerh Collins, Ph.D., who will join the Company on O ctober 3, 2022, will assume the role of Chief Technical Operations and Quality Officer of the Company, effective January 1, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Juan Andres changed role as President, Strategic Partnerships and Enterprise Expansion at Moderna, Inc..

Action: will transition into
Role: President, Strategic Partnerships and Enterprise Expansion

Exact text from the filing

On September 29, 2022, Moderna, Inc. (the “Company”) announced that Juan Andres, the Company’s Chief Technical Operations and Quality Officer, will transition into a new role as President, Strategic Partnerships and Enterprise Expansion of the Company, effective January 1, 2023.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Jerh Collins was appointed as Chief Technical Operations and Quality Officer at Moderna, Inc..

Action: will assume
Role: Chief Technical Operations and Quality Officer

Exact text from the filing

The Company further announced that Dr. Jerh Collins, Ph.D., who will join the Company on O ctober 3, 2022, will assume the role of Chief Technical Operations and Quality Officer of the Company, effective January 1, 2023.

View on SEC.gov

Moderna, Inc. filing history →

Source: SEC EDGAR

accession 0001682852-22-000045

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.